STOCK TITAN

[Form 4/A] Iridex Corp Amended Insider Trading Activity

Filing Impact
(Low)
Filing Sentiment
(Neutral)
Form Type
4/A
Rhea-AI Filing Summary

This Form 4/A amendment reports insider trading activity for Patrick Mercer, President and CEO of Iridex Corp (IRIX), correcting a filing from June 17, 2025. The transactions occurred on June 13, 2025 and include two key components:

  • Restricted Stock Units (RSUs): Acquired 33,370 RSUs at $0.94 per share. These RSUs vest over three years, with one-third vesting annually starting June 13, 2026, contingent on continued service
  • Stock Options: Granted rights to purchase 111,240 shares of common stock at an exercise price of $0.94 per share. These options vest over three years (one-third annually) and expire on June 13, 2032

Following these transactions, Mercer directly owns 420,100 shares. The equity awards were granted under the company's 2008 Equity Incentive Plan and are exempt under Rule 16b-3. This compensation structure aligns the CEO's interests with long-term shareholder value through significant equity ownership requirements and performance incentives.

Questa modifica al Modulo 4/A segnala l'attività di trading interno di Patrick Mercer, Presidente e CEO di Iridex Corp (IRIX), correggendo una dichiarazione del 17 giugno 2025. Le operazioni sono avvenute il 13 giugno 2025 e comprendono due elementi principali:

  • Unità di Azioni Vincolate (RSU): Acquisizione di 33.370 RSU a 0,94$ per azione. Queste RSU maturano in tre anni, con un terzo che matura ogni anno a partire dal 13 giugno 2026, subordinatamente al mantenimento del servizio.
  • Opzioni su Azioni: Concessi diritti di acquisto per 111.240 azioni ordinarie a un prezzo di esercizio di 0,94$ per azione. Queste opzioni maturano in tre anni (un terzo ogni anno) e scadono il 13 giugno 2032.

Dopo queste operazioni, Mercer possiede direttamente 420.100 azioni. Le assegnazioni azionarie sono state concesse nell'ambito del Piano di Incentivi Azionari 2008 della società e sono esenti ai sensi della Regola 16b-3. Questa struttura di compenso allinea gli interessi del CEO con il valore a lungo termine degli azionisti, tramite requisiti significativi di proprietà azionaria e incentivi legati alla performance.

Esta enmienda al Formulario 4/A informa sobre la actividad de operaciones internas de Patrick Mercer, Presidente y CEO de Iridex Corp (IRIX), corrigiendo una presentación del 17 de junio de 2025. Las transacciones ocurrieron el 13 de junio de 2025 e incluyen dos componentes clave:

  • Unidades de Acciones Restringidas (RSUs): Adquisición de 33,370 RSUs a 0,94$ por acción. Estas RSUs se consolidan en tres años, con un tercio consolidándose anualmente a partir del 13 de junio de 2026, condicionado al servicio continuo.
  • Opciones sobre Acciones: Concesión de derechos para comprar 111,240 acciones ordinarias a un precio de ejercicio de 0,94$ por acción. Estas opciones se consolidan en tres años (un tercio anual) y expirarán el 13 de junio de 2032.

Tras estas transacciones, Mercer posee directamente 420,100 acciones. Las concesiones de capital se otorgaron bajo el Plan de Incentivos de Capital de 2008 de la empresa y están exentas bajo la Regla 16b-3. Esta estructura de compensación alinea los intereses del CEO con el valor a largo plazo para los accionistas mediante requisitos significativos de propiedad de acciones e incentivos por desempeño.

이 Form 4/A 수정서는 Iridex Corp(IRIX)의 사장 겸 CEO인 Patrick Mercer의 내부자 거래 활동을 보고하며, 2025년 6월 17일 제출된 문서를 정정합니다. 거래는 2025년 6월 13일에 이루어졌으며 두 가지 주요 내용이 포함되어 있습니다:

  • 제한 주식 단위(RSU): 주당 0.94달러에 33,370 RSU를 취득했습니다. 이 RSU는 3년에 걸쳐 베스팅되며, 2026년 6월 13일부터 매년 3분의 1씩 베스팅되며 계속 근무 조건이 부과됩니다.
  • 주식 옵션: 주당 0.94달러의 행사가격으로 보통주 111,240주를 구매할 권리를 부여받았습니다. 이 옵션은 3년에 걸쳐 베스팅되며(매년 3분의 1씩), 2032년 6월 13일에 만료됩니다.

이 거래 이후 Mercer는 직접 420,100주를 보유하고 있습니다. 주식 보상은 회사의 2008년 주식 인센티브 플랜에 따라 부여되었으며, 규칙 16b-3에 따라 면제됩니다. 이 보상 구조는 CEO의 이익을 장기 주주 가치와 일치시키기 위해 상당한 주식 보유 요건과 성과 인센티브를 포함합니다.

Cette modification du formulaire 4/A rapporte l'activité d'initié de Patrick Mercer, président et PDG d'Iridex Corp (IRIX), corrigeant une déclaration du 17 juin 2025. Les transactions ont eu lieu le 13 juin 2025 et comprennent deux éléments clés :

  • Unités d'actions restreintes (RSU) : acquisition de 33 370 RSU à 0,94 $ par action. Ces RSU sont acquises sur trois ans, un tiers chaque année à partir du 13 juin 2026, sous réserve de la poursuite du service.
  • Options d'achat d'actions : octroi du droit d'acheter 111 240 actions ordinaires à un prix d'exercice de 0,94 $ par action. Ces options sont acquises sur trois ans (un tiers chaque année) et expirent le 13 juin 2032.

Après ces transactions, Mercer détient directement 420 100 actions. Les attributions d'actions ont été accordées dans le cadre du Plan d'incitation en actions de 2008 de la société et sont exemptées en vertu de la règle 16b-3. Cette structure de rémunération aligne les intérêts du PDG sur la valeur à long terme des actionnaires grâce à des exigences importantes de détention d'actions et des incitations à la performance.

Diese Änderung des Formulars 4/A berichtet über Insider-Handelsaktivitäten von Patrick Mercer, Präsident und CEO von Iridex Corp (IRIX), und korrigiert eine Einreichung vom 17. Juni 2025. Die Transaktionen fanden am 13. Juni 2025 statt und umfassen zwei wesentliche Bestandteile:

  • Restricted Stock Units (RSUs): Erwerb von 33.370 RSUs zu einem Preis von 0,94 USD pro Aktie. Diese RSUs werden über drei Jahre vestet, wobei jeweils ein Drittel jährlich ab dem 13. Juni 2026 vestet, vorbehaltlich der fortgesetzten Dienstzeit.
  • Aktienoptionen: Gewährung von Rechten zum Kauf von 111.240 Stammaktien zu einem Ausübungspreis von 0,94 USD pro Aktie. Diese Optionen vesten über drei Jahre (jeweils ein Drittel jährlich) und verfallen am 13. Juni 2032.

Nach diesen Transaktionen besitzt Mercer direkt 420.100 Aktien. Die Aktienzuteilungen wurden im Rahmen des Aktienanreizplans 2008 des Unternehmens gewährt und sind gemäß Regel 16b-3 ausgenommen. Diese Vergütungsstruktur richtet die Interessen des CEO mit dem langfristigen Wert der Aktionäre durch bedeutende Aktienbesitzanforderungen und Leistungsanreize aus.

Positive
  • CEO Patrick Mercer received significant equity compensation package: 33,370 RSUs ($31,368) and 111,240 stock options, demonstrating long-term alignment with shareholders
Negative
  • None.

Questa modifica al Modulo 4/A segnala l'attività di trading interno di Patrick Mercer, Presidente e CEO di Iridex Corp (IRIX), correggendo una dichiarazione del 17 giugno 2025. Le operazioni sono avvenute il 13 giugno 2025 e comprendono due elementi principali:

  • Unità di Azioni Vincolate (RSU): Acquisizione di 33.370 RSU a 0,94$ per azione. Queste RSU maturano in tre anni, con un terzo che matura ogni anno a partire dal 13 giugno 2026, subordinatamente al mantenimento del servizio.
  • Opzioni su Azioni: Concessi diritti di acquisto per 111.240 azioni ordinarie a un prezzo di esercizio di 0,94$ per azione. Queste opzioni maturano in tre anni (un terzo ogni anno) e scadono il 13 giugno 2032.

Dopo queste operazioni, Mercer possiede direttamente 420.100 azioni. Le assegnazioni azionarie sono state concesse nell'ambito del Piano di Incentivi Azionari 2008 della società e sono esenti ai sensi della Regola 16b-3. Questa struttura di compenso allinea gli interessi del CEO con il valore a lungo termine degli azionisti, tramite requisiti significativi di proprietà azionaria e incentivi legati alla performance.

Esta enmienda al Formulario 4/A informa sobre la actividad de operaciones internas de Patrick Mercer, Presidente y CEO de Iridex Corp (IRIX), corrigiendo una presentación del 17 de junio de 2025. Las transacciones ocurrieron el 13 de junio de 2025 e incluyen dos componentes clave:

  • Unidades de Acciones Restringidas (RSUs): Adquisición de 33,370 RSUs a 0,94$ por acción. Estas RSUs se consolidan en tres años, con un tercio consolidándose anualmente a partir del 13 de junio de 2026, condicionado al servicio continuo.
  • Opciones sobre Acciones: Concesión de derechos para comprar 111,240 acciones ordinarias a un precio de ejercicio de 0,94$ por acción. Estas opciones se consolidan en tres años (un tercio anual) y expirarán el 13 de junio de 2032.

Tras estas transacciones, Mercer posee directamente 420,100 acciones. Las concesiones de capital se otorgaron bajo el Plan de Incentivos de Capital de 2008 de la empresa y están exentas bajo la Regla 16b-3. Esta estructura de compensación alinea los intereses del CEO con el valor a largo plazo para los accionistas mediante requisitos significativos de propiedad de acciones e incentivos por desempeño.

이 Form 4/A 수정서는 Iridex Corp(IRIX)의 사장 겸 CEO인 Patrick Mercer의 내부자 거래 활동을 보고하며, 2025년 6월 17일 제출된 문서를 정정합니다. 거래는 2025년 6월 13일에 이루어졌으며 두 가지 주요 내용이 포함되어 있습니다:

  • 제한 주식 단위(RSU): 주당 0.94달러에 33,370 RSU를 취득했습니다. 이 RSU는 3년에 걸쳐 베스팅되며, 2026년 6월 13일부터 매년 3분의 1씩 베스팅되며 계속 근무 조건이 부과됩니다.
  • 주식 옵션: 주당 0.94달러의 행사가격으로 보통주 111,240주를 구매할 권리를 부여받았습니다. 이 옵션은 3년에 걸쳐 베스팅되며(매년 3분의 1씩), 2032년 6월 13일에 만료됩니다.

이 거래 이후 Mercer는 직접 420,100주를 보유하고 있습니다. 주식 보상은 회사의 2008년 주식 인센티브 플랜에 따라 부여되었으며, 규칙 16b-3에 따라 면제됩니다. 이 보상 구조는 CEO의 이익을 장기 주주 가치와 일치시키기 위해 상당한 주식 보유 요건과 성과 인센티브를 포함합니다.

Cette modification du formulaire 4/A rapporte l'activité d'initié de Patrick Mercer, président et PDG d'Iridex Corp (IRIX), corrigeant une déclaration du 17 juin 2025. Les transactions ont eu lieu le 13 juin 2025 et comprennent deux éléments clés :

  • Unités d'actions restreintes (RSU) : acquisition de 33 370 RSU à 0,94 $ par action. Ces RSU sont acquises sur trois ans, un tiers chaque année à partir du 13 juin 2026, sous réserve de la poursuite du service.
  • Options d'achat d'actions : octroi du droit d'acheter 111 240 actions ordinaires à un prix d'exercice de 0,94 $ par action. Ces options sont acquises sur trois ans (un tiers chaque année) et expirent le 13 juin 2032.

Après ces transactions, Mercer détient directement 420 100 actions. Les attributions d'actions ont été accordées dans le cadre du Plan d'incitation en actions de 2008 de la société et sont exemptées en vertu de la règle 16b-3. Cette structure de rémunération aligne les intérêts du PDG sur la valeur à long terme des actionnaires grâce à des exigences importantes de détention d'actions et des incitations à la performance.

Diese Änderung des Formulars 4/A berichtet über Insider-Handelsaktivitäten von Patrick Mercer, Präsident und CEO von Iridex Corp (IRIX), und korrigiert eine Einreichung vom 17. Juni 2025. Die Transaktionen fanden am 13. Juni 2025 statt und umfassen zwei wesentliche Bestandteile:

  • Restricted Stock Units (RSUs): Erwerb von 33.370 RSUs zu einem Preis von 0,94 USD pro Aktie. Diese RSUs werden über drei Jahre vestet, wobei jeweils ein Drittel jährlich ab dem 13. Juni 2026 vestet, vorbehaltlich der fortgesetzten Dienstzeit.
  • Aktienoptionen: Gewährung von Rechten zum Kauf von 111.240 Stammaktien zu einem Ausübungspreis von 0,94 USD pro Aktie. Diese Optionen vesten über drei Jahre (jeweils ein Drittel jährlich) und verfallen am 13. Juni 2032.

Nach diesen Transaktionen besitzt Mercer direkt 420.100 Aktien. Die Aktienzuteilungen wurden im Rahmen des Aktienanreizplans 2008 des Unternehmens gewährt und sind gemäß Regel 16b-3 ausgenommen. Diese Vergütungsstruktur richtet die Interessen des CEO mit dem langfristigen Wert der Aktionäre durch bedeutende Aktienbesitzanforderungen und Leistungsanreize aus.

SEC Form 4
FORM 4 UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940
OMB APPROVAL
OMB Number: 3235-0287
Estimated average burden
hours per response: 0.5
Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).
Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.
1. Name and Address of Reporting Person*
Mercer Patrick

(Last) (First) (Middle)
1212 TERRA BELLA AVENUE

(Street)
MOUNTAIN VIEW CA 94043

(City) (State) (Zip)
2. Issuer Name and Ticker or Trading Symbol
IRIDEX CORP [ IRIX ]
5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)
Director 10% Owner
X Officer (give title below) Other (specify below)
President and CEO
3. Date of Earliest Transaction (Month/Day/Year)
06/13/2025
4. If Amendment, Date of Original Filed (Month/Day/Year)
06/17/2025
6. Individual or Joint/Group Filing (Check Applicable Line)
X Form filed by One Reporting Person
Form filed by More than One Reporting Person
Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3) 2. Transaction Date (Month/Day/Year) 2A. Deemed Execution Date, if any (Month/Day/Year) 3. Transaction Code (Instr. 8) 4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5) 5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4) 6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4) 7. Nature of Indirect Beneficial Ownership (Instr. 4)
Code V Amount (A) or (D) Price
Common Stock 06/13/2025 A 33,370(1) A $0.94 420,100 D
Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned
(e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3) 2. Conversion or Exercise Price of Derivative Security 3. Transaction Date (Month/Day/Year) 3A. Deemed Execution Date, if any (Month/Day/Year) 4. Transaction Code (Instr. 8) 5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5) 6. Date Exercisable and Expiration Date (Month/Day/Year) 7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4) 8. Price of Derivative Security (Instr. 5) 9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4) 10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4) 11. Nature of Indirect Beneficial Ownership (Instr. 4)
Code V (A) (D) Date Exercisable Expiration Date Title Amount or Number of Shares
Common Stock (right to buy)(2) $0.94 06/13/2025 A 111,240 (3) 06/13/2032 Common Stock 111,240 $0 111,240 D
Explanation of Responses:
1. Each share is represented by a restricted stock unit (RSU). Each RSU represents a contingent right to receive one share of the Issuer's Common Stock upon settlement. The RSUs vest as to one-third of the shares on June 13, 2026 and each one-year anniversary thereafter, subject to the Reporting Person continuing as a service provider through each such date.
2. This option was granted pursuant to the Company's 2008 Equity Incentive Plan, as amended, and is exempt pursuant to Rule16b-3.
3. The shares are subject to vesting according to the following schedule: 1/3 of the Shares subject to the Option will vest each one-year anniversary of the date of grant.
/s/ Nilo De Castro, Attorney-in-fact for Patrick Mercer 06/24/2025
** Signature of Reporting Person Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.

FAQ

How many IRIX shares did CEO Patrick Mercer acquire on June 13, 2025?

On June 13, 2025, Patrick Mercer acquired 33,370 restricted stock units (RSUs) at $0.94 per share and 111,240 stock options of IRIX common stock.

What is the vesting schedule for Patrick Mercer's new IRIX RSUs?

The RSUs vest in three equal annual installments, with one-third of the shares vesting on June 13, 2026, and each one-year anniversary thereafter, contingent on Mercer continuing as a service provider through each vesting date.

What is the expiration date for IRIX CEO's stock options granted in June 2025?

The stock options granted to Patrick Mercer on June 13, 2025, have an expiration date of June 13, 2032, giving him a 7-year exercise window.

How many IRIX shares does Patrick Mercer own after the June 2025 transaction?

Following the reported transaction, Patrick Mercer directly owns 420,100 shares of IRIX common stock, plus 111,240 stock options and 33,370 RSUs subject to vesting.

What is the exercise price of IRIX stock options granted to CEO in June 2025?

The stock options were granted with an exercise price of $0.94 per share under the Company's 2008 Equity Incentive Plan.
Iridex

NASDAQ:IRIX

IRIX Rankings

IRIX Latest News

IRIX Latest SEC Filings

IRIX Stock Data

15.98M
12.00M
20.67%
19.45%
1.6%
Medical Devices
Electromedical & Electrotherapeutic Apparatus
Link
United States
MOUNTAIN VIEW